Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Apr. 30, 2025	Mar. 31, 2025	Dec. 31, 2024
Commitments and Contingencies [Line Items]
Initial Sale		$ 2,200,000
Accounts recievable from non controlling interest		3,214,409	$ 3,267,948
Renergen Limited [Member] | Subsequent Event [Member]
Commitments and Contingencies [Line Items]
Payment of exclusivity fee	$ 10,000,000
Share Purchase Agreement relating to PET Labs [Member]
Commitments and Contingencies [Line Items]
Property and equipment payment		2,000,000
Payble amount		264,750
Additional paid amount		750,000
Damage amount		500,000
Initial Sale		1,500,000
Accounts recievable from non controlling interest		$ 485,250
Agreed to purchase ordinary shares		51
Percentage of issued share capital		51.00%
Option to purchase remaining ordinary shares		49
Percentage of remaining issued share capital		49.00%